Akili Stock (NASDAQ: AKLI) stock price, news, charts, stock research, profile.
Open | $0.240 |
Close | $0.245 |
Volume / Avg. | 51.509K / 2.365M |
Day Range | 0.237 - 0.260 |
52 Wk Range | 0.191 - 1.670 |
Market Cap | $19.256M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 0.33% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Akili (NASDAQ: AKLI) through any online brokerage.
Other companies in Akili’s space includes: OptimizeRx (NASDAQ:OPRX), Sharecare (NASDAQ:SHCR), Trxade Health (NASDAQ:MEDS), TruBridge (NASDAQ:TBRG) and Bullfrog AI Hldgs (NASDAQ:BFRG).
The latest price target for Akili (NASDAQ: AKLI) was reported by Credit Suisse on Friday, August 11, 2023. The analyst firm set a price target for 4.00 expecting AKLI to rise to within 12 months (a possible 1543.39% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Akili (NASDAQ: AKLI) is $0.2434 last updated April 26, 2024 at 9:25 AM EDT.
There are no upcoming dividends for Akili.
Akili’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Akili.
Akili is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.